Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. freshman Good
|
New words:
abandoned, Advisory, automated, BC, Cephalon, certified, compounding, consummated, core, customary, Diego, discontinue, fact, fewer, gain, Hillsboro, imclone, impaired, Iressa, KGaA, landscape, leveraged, Likewise, monitor, ocular, Oregon, outlay, pancreactic, paper, permanent, perspective, preacquisition, preexisting, processing, published, repackaging, repay, repeat, restructuring, revolving, sooner, sputum, sterility, structure, sublease, summer, tangible, technique, thereon, Treanda, unclear, vinorelbine
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 15.1 Letter Regarding Unaudited Interim Financial Information
- 31.1 Certification of Chief Executive Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended
- 31.2 Certification of Chief Financial Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended
- 32.1 Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
Related press release
Genentech similar filings
Filing view
External links